AI-based drug discovery company Recursion raises $239M Series D and partners with pharma giant Bayer to develop new treatments for fibrotic diseases — Startups that want to leverage artificial intelligence in drug discovery are a dime a dozen in today's biotech landscape.
from Techmeme https://ift.tt/33otleh
via A.I .Kung Fu
Responses